title: rHuEPO increases urinary excretion of fibrin degradation products in haemodialysed patients.
authors.forename: R
authors.initials: R
authors.lastname: Gareau
authors.forename: M G
authors.initials: MG
authors.lastname: Gagnon
authors.forename: C
authors.initials: C
authors.lastname: Ayotte
authors.forename: C
authors.initials: C
authors.lastname: Chénard
authors.forename: G R
authors.initials: GR
authors.lastname: Brisson
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D004921:Erythropoietin / Q000494:pharmacology*; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000652:urine*; D005340:Fibrinogen / Q000378:metabolism; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000494:pharmacology; D006435:Renal Dialysis
chemical_list: D005338:Fibrin Fibrinogen Degradation Products; D011994:Recombinant Proteins; D004921:Erythropoietin; D005340:Fibrinogen